Similar articles

• Sunitinib Alone or after Nephrectomy in Renal Cancer.

  Bex A, Powles T, Haanen J. Bex A, et al. N Engl J Med. 2018 Nov 8;379(19):1877-8. doi: 10.1056/NEJMc1811532. N Engl J Med. 2018. PMID: 30406978 No abstract available.
• Sunitinib Alone or after Nephrectomy in Renal Cancer.

  Kondoh CN, Miura Y, Yamanaka T. Kondoh CN, et al. N Engl J Med. 2018 Nov 8;379(19):1877. doi: 10.1056/NEJMc1811532. N Engl J Med. 2018. PMID: 30406977 No abstract available.
• Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy.

  Struss WJ, Black PC. Struss WJ, et al. Urology. 2017 Jul;105:13. doi: 10.1016/j.urology.2017.01.006. Epub 2017 Jan 12. Urology. 2017. PMID: 28089886 No abstract available.
• Sunitinib therapy in renal cell carcinoma.

  O'Brien MF, Russo P, Motzer RJ. O'Brien MF, et al. BJU Int. 2008 Jun;101(11):1339-42. doi: 10.1111/j.1464-410X.2008.07506.x. Epub 2008 Feb 18. BJU Int. 2008. PMID: 18284408 Review. No abstract available.
• Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.

  Fokt RM, Templeton A, Gillessen S, Ohlschlegel C, Schmid HP. Fokt RM, et al. Urol Int. 2009;83(1):122-4. doi: 10.1159/000224882. Epub 2009 Jul 27. Urol Int. 2009. PMID: 19641373 Review.